Life sciences retreat drives 566,728 SQFT of losses in R&D sector as AI funding surges to $1.23 billion; industrial sees $71.1 million in...
ByThe RegistryNovember 3, 2025Industry experts cautiously optimistic about healthcare real estate sales in 2025 Healthcare real estate professionals are showing measured optimism for the medical outpatient...
ByThe RegistryApril 3, 2025By Kate Snyder In South San Francisco, a biotechnology company is extending its lease at a life science and office hub. Surrozen, Inc.,...
ByThe RegistryOctober 8, 2024By Kate Snyder In a move that diverges from prevailing market trends, the Alaska Permanent Fund Corporation has announced an investment of $216.5...
ByThe RegistryMarch 4, 2024DENVER – Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today...
ByThe RegistryDecember 20, 2023By The Registry Staff Another firm in the Bay Area is taking steps to exit its lease. Graphite Bio, a gene editing company,...
ByThe RegistryNovember 2, 2023Immediately Accretive Transaction that Positions Combined Company for Offense Scott Brinker to Serve as President and Chief Executive Officer of Combined Company; John...
ByThe RegistryOctober 31, 2023By The Registry Staff A clinical-stage pharmaceutical firm is making changes to its office space arrangements. Pliant Therapeutics, a company specializing in treatments...
ByThe RegistryOctober 11, 2023By Jon Peterson South San Francisco has had a significant amount of development over the last few years, and it has become an...
ByThe RegistryDecember 9, 2022Scott Brinker Appointed President and Chief Executive Officer and Elected as Member of the Board; Tom Herzog Steps Down as Chief Executive Officer...
ByThe RegistryOctober 7, 2022DENVER, Feb. 8, 2022 — Healthpeak Properties, Inc. (NYSE: PEAK) announced today the execution of long-term leases with Graphite Bio, Inc. and another leading biotech...
ByThe RegistryFebruary 9, 2022Next-generation gene editing company to occupy three full floors of ground-up, Class A life sciences development in one of the top biotech markets...
ByThe RegistryJanuary 27, 2022 
Signup for news and special announcements!
You have successfully joined our subscriber list.